Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Brain Res. 2016 May 25;1646:139–151. doi: 10.1016/j.brainres.2016.05.026

Figure 2.

Figure 2

Suppression of miR-34a target proteins in AD patients brain regions. Representative western blot of synaptic plasticity related proteins, oxidative phosphorylation proteins and enzymatic glycolysis proteins probed with respective protein specific antibody in protein samples isolated from four AD patients (B&B stage VI) and AMC are shown in the TC and CB. Representative western blots of β-actin were used as normalization controls. Densitometric quantification of respective protein levels are shown in the adjacent bar graph (fold difference, average of control = 1, data are mean ± SEM, n = 4, *p < 0.05 **p <0.01 ***p<0.001.